or
Remember me
Back
It is still pricey. They are trading at around 70 times annual adjusted ebitda and 42% yoy growth.
Acuityads is growing ebitda at around 40% yoy and you can purchase them for 5.4 times ebitda.
Receive investor kits and email updates from Stockhouse and directly from these companies.